Phase III Randomized Study of Crenolanib Versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects With FLT3 Mutated Acute Myeloid Leukemia
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Crenolanib (Primary) ; Cytarabine; Daunorubicin; Midostaurin
- Indications Acute myeloid leukaemia
- Focus Registrational; Therapeutic Use
- Sponsors AROG Pharmaceuticals
- 01 Jul 2018 Planned initiation date changed from 1 May 2018 to 1 Aug 2018.
- 16 Jan 2018 Planned initiation date changed from 1 Nov 2017 to 1 May 2018.
- 29 Aug 2017 New trial record